Article
The OPN gene polymorphism confers the susceptibility and response to Ara-C based chemotherapy in Chinese AML patients.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology - 1 Jan 2015
Zhang Rong, Yang Wei, Li Ying Chun, Zhang Guo Jun, Yao Kun, Hu Rong, Wu Bin
Abstract excerpt
AIM: To investigate the possible association between the Osteopontin (OPN) gene polymorphisms and the susceptibility and chemotherapy response of acute myeloid leukemia patients. METHODS: A total of 381 patients with de nova AML and 430 healthy controls were enrolled. All patients received Ara-C-based standard induction chemotherapy regimens, and the treatment response was evaluated. Several polymorphisms in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
